348 related articles for article (PubMed ID: 32306456)
1. Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease.
Sangineto M; Grabherr F; Adolph TE; Grander C; Reider S; Jaschke N; Mayr L; Schwärzler J; Dallio M; Moschen AR; Moschetta A; Sabbà C; Tilg H
Liver Int; 2020 Jul; 40(7):1610-1619. PubMed ID: 32306456
[TBL] [Abstract][Full Text] [Related]
2. Hydroxytyrosol attenuates ethanol-induced liver injury by ameliorating steatosis, oxidative stress and hepatic inflammation by interfering STAT3/iNOS pathway.
Fang X; Cao J; Tao Z; Yang Z; Dai Y; Zhao L
Redox Rep; 2023 Dec; 28(1):2187564. PubMed ID: 36932927
[No Abstract] [Full Text] [Related]
3. Recovery of ethanol-induced
Grander C; Adolph TE; Wieser V; Lowe P; Wrzosek L; Gyongyosi B; Ward DV; Grabherr F; Gerner RR; Pfister A; Enrich B; Ciocan D; Macheiner S; Mayr L; Drach M; Moser P; Moschen AR; Perlemuter G; Szabo G; Cassard AM; Tilg H
Gut; 2018 May; 67(5):891-901. PubMed ID: 28550049
[TBL] [Abstract][Full Text] [Related]
4. A combination of Pueraria lobata and Silybum marianum protects against alcoholic liver disease in mice.
Feng R; Chen JH; Liu CH; Xia FB; Xiao Z; Zhang X; Wan JB
Phytomedicine; 2019 May; 58():152824. PubMed ID: 30836218
[TBL] [Abstract][Full Text] [Related]
5. Recovery of
Sangineto M; Grander C; Grabherr F; Mayr L; Enrich B; Schwärzler J; Dallio M; Bukke VN; Moola A; Moschetta A; Adolph TE; Sabbà C; Serviddio G; Tilg H
Gut Microbes; 2022; 14(1):2089006. PubMed ID: 35786161
[TBL] [Abstract][Full Text] [Related]
6. Dual therapy with zinc acetate and rifaximin prevents from ethanol-induced liver fibrosis by maintaining intestinal barrier integrity.
Fujimoto Y; Kaji K; Nishimura N; Enomoto M; Murata K; Takeda S; Takaya H; Kawaratani H; Moriya K; Namisaki T; Akahane T; Yoshiji H
World J Gastroenterol; 2021 Dec; 27(48):8323-8342. PubMed ID: 35068872
[TBL] [Abstract][Full Text] [Related]
7. Lactobacillus rhamnosus GG combined with inosine ameliorates alcohol-induced liver injury through regulation of intestinal barrier and Treg/Th1 cells.
Zhu Y; Wang X; Zhu L; Tu Y; Chen W; Gong L; Pan T; Lin H; Lin J; Sun H; Ge Y; Wei L; Guo Y; Lu C; Chen Y; Xu L
Toxicol Appl Pharmacol; 2022 Mar; 439():115923. PubMed ID: 35176292
[TBL] [Abstract][Full Text] [Related]
8. Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.
Zhang W; Sun Q; Zhong W; Sun X; Zhou Z
Alcohol Clin Exp Res; 2016 May; 40(5):988-99. PubMed ID: 27062444
[TBL] [Abstract][Full Text] [Related]
9. Computational repositioning of dimethyl fumarate for treating alcoholic liver disease.
Zhang Y; Zhao S; Fu Y; Yan L; Feng Y; Chen Y; Wu Y; Deng Y; Zhang G; Chen Z; Chen Y; Liu T
Cell Death Dis; 2020 Aug; 11(8):641. PubMed ID: 32811823
[TBL] [Abstract][Full Text] [Related]
10. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
11. Lipocalin 2 drives neutrophilic inflammation in alcoholic liver disease.
Wieser V; Tymoszuk P; Adolph TE; Grander C; Grabherr F; Enrich B; Pfister A; Lichtmanegger L; Gerner R; Drach M; Moser P; Zoller H; Weiss G; Moschen AR; Theurl I; Tilg H
J Hepatol; 2016 Apr; 64(4):872-80. PubMed ID: 26682726
[TBL] [Abstract][Full Text] [Related]
12. Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice.
Zhang X; Wang H; Yin P; Fan H; Sun L; Liu Y
Lipids Health Dis; 2017 Feb; 16(1):44. PubMed ID: 28228158
[TBL] [Abstract][Full Text] [Related]
13. Bifidobacterium longum subsp. longum BL21 ameliorates alcoholic liver disease in mice through enhancement of the hepatic antioxidant capacity and modulation of the gut microbiota.
Dong Y; Wu Z; Gai Z; Han M
J Appl Microbiol; 2023 Nov; 134(11):. PubMed ID: 37930723
[TBL] [Abstract][Full Text] [Related]
14. 24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγ.
Grander C; Meyer M; Steinacher D; Claudel T; Hausmann B; Pjevac P; Grabherr F; Oberhuber G; Grander M; Brigo N; Jukic A; Schwärzler J; Weiss G; Adolph TE; Trauner M; Tilg H
JHEP Rep; 2023 Nov; 5(11):100872. PubMed ID: 37818230
[TBL] [Abstract][Full Text] [Related]
15. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.
Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W
J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899
[TBL] [Abstract][Full Text] [Related]
16. Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice.
Wu WB; Chen YY; Zhu B; Peng XM; Zhang SW; Zhou ML
Biochimie; 2015 Aug; 115():86-92. PubMed ID: 26025474
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in Mice.
Ambade A; Lowe P; Kodys K; Catalano D; Gyongyosi B; Cho Y; Iracheta-Vellve A; Adejumo A; Saha B; Calenda C; Mehta J; Lefebvre E; Vig P; Szabo G
Hepatology; 2019 Mar; 69(3):1105-1121. PubMed ID: 30179264
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-32γ attenuates ethanol-induced liver injury by the inhibition of cytochrome P450 2E1 expression and inflammatory responses.
Lee DH; Kim DH; Hwang CJ; Song S; Han SB; Kim Y; Yoo HS; Jung YS; Kim SH; Yoon DY; Hong JT
Clin Sci (Lond); 2015 May; 128(10):695-706. PubMed ID: 25583360
[TBL] [Abstract][Full Text] [Related]
19. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
[TBL] [Abstract][Full Text] [Related]
20. Berbamine ameliorates ethanol-induced liver injury by inhibition of hepatic inflammation in mice.
Liu XY; Chen GN; DU GM; Pan Y; Song WQ; Jiang TW; Liu HL
Chin J Nat Med; 2020 Mar; 18(3):186-195. PubMed ID: 32245588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
